Publication:
Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists

dc.contributor.authorLobos-Bejarano, Jose M.
dc.contributor.authorCastellanos Rodriguez, Angel
dc.contributor.authorBarrios, Vivencio
dc.contributor.authorEscobar, Carlos
dc.contributor.authorPolo-Garcia, Jose
dc.contributor.authorCarlos del Castillo-Rodriguez, Jose
dc.contributor.authorVargas-Ortega, Diego
dc.contributor.authorLopez-Pineda, Adriana
dc.contributor.authorPrieto-Valiente, Luis
dc.contributor.authorLip, Gregory Y. H.
dc.contributor.authorPAULA Study Team
dc.contributor.authoraffiliation[Lobos-Bejarano, Jose M.] East Area Primary Care, Jazmin Primary Care Hlth Ctr, Madrid, Spain
dc.contributor.authoraffiliation[Castellanos Rodriguez, Angel] East Area Primary Care, Ciudad Periodistas Primary Care Hlth Ctr, Madrid, Spain
dc.contributor.authoraffiliation[Barrios, Vivencio] Univ Hosp Ramon & Cajal, Dept Cardiol, Madrid, Spain
dc.contributor.authoraffiliation[Escobar, Carlos] Univ Hosp La Paz, Dept Cardiol, Madrid, Spain
dc.contributor.authoraffiliation[Polo-Garcia, Jose] Primary Care Hlth Ctr Casar de Caceres, Caceres, Spain
dc.contributor.authoraffiliation[Carlos del Castillo-Rodriguez, Jose] Hosp San Juan Dios, Prevent Cardiol Unit, Santa Cruz De Tenerife, Spain
dc.contributor.authoraffiliation[Vargas-Ortega, Diego] Hosp Poniente El Ejido, High Resolut Hospitalizat Unit, Hosp El Toyo, Almeria, Spain
dc.contributor.authoraffiliation[Lopez-Pineda, Adriana] Miguel Hernandez Univ, Dept Clin Med, Alacant, Spain
dc.contributor.authoraffiliation[Prieto-Valiente, Luis] Univ Catolica San Antonio Murcia, Med Biostat, Murcia, Spain
dc.contributor.authoraffiliation[Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham, W Midlands, England
dc.contributor.funderBayer Hispania S.L
dc.date.accessioned2023-02-12T02:21:33Z
dc.date.available2023-02-12T02:21:33Z
dc.date.issued2017-09-01
dc.description.abstractBackground and PurposeChronic kidney disease (CKD) has been related to poor anticoagulation control and an increased risk of bleeding. This study aims to evaluate the association between impaired renal function (eGFR 2 points) showed no significant predictive capacity for TTR (AUC 0.528, P=.354). The average TTR was similar for both sexes (P=.255), but with a higher percentage of males subjects with TTR 65% (P=.013).ConclusionChronic kidney disease is associated with poor anticoagulation control in patients with non-valvular AF taking VKA. The SAMe-TT2R2 score was not predictive of poor TTR in the subgroup with CKD, although a modest predictive value for poor TTR was found in those without CKD.
dc.identifier.doi10.1111/ijcp.12974
dc.identifier.essn1742-1241
dc.identifier.issn1368-5031
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijcp.12974
dc.identifier.urihttp://hdl.handle.net/10668/18988
dc.identifier.wosID411088400002
dc.issue.number9
dc.journal.titleInternational journal of clinical practice
dc.journal.titleabbreviationInt. j. clin. pract.
dc.language.isoen
dc.organizationAPES Hospital de Poniente de Almería
dc.publisherWiley-hindawi
dc.rights.accessRightsopen access
dc.subjectanticoagulation
dc.subjectatrial fibrillation
dc.subjectchronic kidney disease
dc.subjectvitamin K antagonist
dc.subjectChronic kidney-disease
dc.subjectSame-tt2r2 score
dc.subjectStroke
dc.subjectQuality
dc.subjectWarfarin
dc.subjectRisk
dc.subjectMortality
dc.subjectSpain
dc.subjectCare
dc.subjectInr
dc.titleInfluence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number71
dc.wostypeArticle
dspace.entity.typePublication

Files